Review article: the antimicrobial effects of rifaximin on the gut microbiota

被引:55
作者
DuPont, H. L. [1 ]
机构
[1] Univ Texas Houston, Sch Publ Hlth, Baylor Coll Med, Ctr Infect Dis,Kelsey Res Fdn, Houston, TX USA
关键词
IN-VITRO ACTIVITY; TRAVELERS DIARRHEA; INTESTINAL MICROBIOTA; DOUBLE-BLIND; DISEASE; FLORA; HOST; HEALTH; RIFAMYCIN; BACTERIA;
D O I
10.1111/apt.13434
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundDisruption of the gut microbiota through use of systemic antimicrobials or activation of the mucosal inflammatory response by pathogens can cause dysregulation of the intestinal mucosa. AimTo explore the mechanisms of action of rifaximin that may underlie its clinical benefits in travellers' diarrhoea (TD). MethodsA literature search was performed using the terms rifaximin' and L/105' in combination with the terms invitro activity', diarrhea', microbiota' and gut flora'. ResultsRifaximin has been traditionally identified as a nonsystemic, broad-spectrum, bactericidal antibiotic. Evidence shows that the activity of rifaximin against enteropathogens in this setting is likely enhanced by its increased solubility in the presence of bile acids in the small intestine. Results of clinical studies show that although rifaximin is efficacious in TD, a clinical cure often occurs without apparent bacterial eradication and with minimal effect on the gut microbiota, suggesting an effect of rifaximin other than direct antibiotic activity. ConclusionsAlthough definitive studies on the effect of rifaximin on the gut microbiota in large cohorts of healthy volunteers or patients have not been published, pre-clinical studies provide some insight. These studies have shown that rifaximin may have effects on both the pathogen and host, including direct effects on pathogenic bacteria (such as reducing the expression of bacterial virulence factors) and indirect effects on the host (such as inhibiting bacterial attachment and internalisation at the intestinal mucosa and reducing mucosal inflammation).
引用
收藏
页码:3 / 10
页数:8
相关论文
共 46 条
[1]   Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles [J].
Brown, Eric L. ;
Xue, Qiong ;
Jiang, Zhi-Dong ;
Xu, Yi ;
DuPont, Herbert L. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) :388-396
[2]   Bile Acids Improve the Antimicrobial Effect of Rifaximin [J].
Darkoh, Charles ;
Lichtenberger, Lenard M. ;
Ajami, Nadim ;
Dial, Elizabeth J. ;
Jiang, Zhi-Dong ;
DuPont, Herbert L. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (09) :3618-3624
[3]   Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations [J].
Debbia, E. A. ;
Maioli, E. ;
Roveta, S. ;
Marchese, A. .
JOURNAL OF CHEMOTHERAPY, 2008, 20 (02) :186-194
[4]  
DESCOMBE JJ, 1994, INT J CLIN PHARM RES, V14, P51
[5]   Treatment of travelers' diarrhea: Randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone [J].
DuPont, Herbert L. ;
Jiang, Zhi-Dong ;
Belkind-Gerson, Jaime ;
Okhuysen, Pablo C. ;
Ericsson, Charles D. ;
Ke, Shi ;
Huang, David B. ;
Dupont, Margaret W. ;
Adachi, Javier A. ;
de la Cabada, F. Javier ;
Taylor, David N. ;
Jaini, Sridvya ;
Sandoval, Francisco Martinez .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (04) :451-456
[6]   Antibacterial chemoprophylaxis in the prevention of traveler's diarrhea: Evaluation of poorly absorbed oral rifaximin [J].
DuPont, HL ;
Jiang, ZD ;
Okhuysen, PC ;
Ericsson, CD ;
de la Cabada, FJ ;
Ke, S ;
DuPont, MW ;
Martinez-Sandoval, F .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S571-S576
[7]   Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci [J].
DuPont, HL ;
Jiang, ZD .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (11) :1009-1011
[8]   Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: A randomized, double-blind clinical trial [J].
DuPont, HL ;
Jiang, ZD ;
Ericsson, CD ;
Adachi, JA ;
Mathewson, JJ ;
DuPont, MW ;
Palazzini, E ;
Riopel, LM ;
Ashley, D ;
Martinez-Sandoval, F .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (11) :1807-1815
[9]   Rifaximin: A nonabsorbed antimicrobial in the therapy of travelers' diarrhea [J].
DuPont, HL ;
Ericsson, CD ;
Mathewson, JJ ;
Palazzini, E ;
DuPont, MW ;
Jiang, ZD ;
Mosavi, A ;
de la Cabada, FJ .
DIGESTION, 1998, 59 (06) :708-714
[10]   Diversity of the human intestinal microbial flora [J].
Eckburg, PB ;
Bik, EM ;
Bernstein, CN ;
Purdom, E ;
Dethlefsen, L ;
Sargent, M ;
Gill, SR ;
Nelson, KE ;
Relman, DA .
SCIENCE, 2005, 308 (5728) :1635-1638